Benitec Biopharma Inc. (BNTC)
NASDAQ · Manufacturing · Pharmaceutical preparations
$9.59−$0.0500 (−0.52%) on the dayAs of the close; data may be delayed.
BNTC price, last 12 months
Key stats
- Previous close
- $9.64
- Open
- $9.70
- Day range
- $9.31 – $9.80
- 52-week range
- $9.26 – $16.76
- Volume
- 107K
- Avg volume (20 days)
- 153.9K
- Market cap
- $334.5M
Performance
1W−13.0%
1M−25.5%
3M−22.5%
6M−11.3%
YTD−28.8%
1Y−31.9%
vs S&P 500, 1Y−48.7 pts
Technicals and fundamentals
About Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $334.5M